Rethinking the standard
In an ideal world, which features does the perfect contrast medium have?
When it comes to angiographic procedures, the use of CO2 as a contrast agent has proved to be an effective alternative to iodinated contrast media. This innovation is particularly advantageous in fields like Vascular Surgery, Interventional Radiology, and Interventional Angiology. Medical-grade Carbon Dioxide offers a fully biocompatible and safe option, suitable for injection into various lumen structures like arterial, venous, and even biliary tracts.
For patients undergoing peripheral angiography, the use of CO2 is highly recommended in cases of renal failure, diabetes, or intolerance to iodinated contrast media, particularly when creatinine levels exceed 1.5 mg/dl. Its unique features set it apart from conventional agents.
Reasons to choose Angiodroid The CO2 Injector
As stated by the European Society for Vascular Surgery, CO2 minimizes the risks of contrast-induced nephropathy (CIN), a leading cause of renal failure. This is because it is 100% biocompatible and gets eliminated through exhalation, posing no burden on the kidneys. Furthermore, CO2 quickly dissolves in the bloodstream and has no maximum dosage limits.
Discomfort during an angiographic procedure can be common for patients. It is crucial to implement measures that prioritize their well-being and enhance their comfort and cooperation.
Angiodroid The CO2 Injector is the only safe and fully automated CO2 injector designed for peripheral angiography. It delivers CO2 at a controlled and consistent pressure, eliminates the “jet effect,” and ensures maximum safety by preventing air contamination.
Woerly, B., & Goyault G. Évolution sur 1 an de l'imagerie CO2 dans l’angioplastie des membres inférieurs. L’Interventionnel n°16, 10-11. 2022
The non-biocompability is the underlying problem of iodinated contrast media. They cause adverse reactions which require additional hospital treatments.
CO2 is a low-cost alternative and reduces the need for supplementary treatments associated with these adverse reactions.
Clinical studies reveal that CO2 angiography reduces hospitalization time by 35%, making it an efficient and valuable choice in daily practice.
Iodinated contrast media remain the gold standard for lesion localization and vascular procedure planning. However, their use come with significant limitations. First, safety concerns arise due to potential side effects. Second, their high viscosity often hinders complete and clear visualization.
Thanks to its high sensitivity and low viscosity, CO2 can be considered as a valuable alternative, enabling enhanced visualization of endoleaks and collateral vessels.
Iodinated contrast media are more radiopaque than the devices used for angiography, which can hinder their detailed visualization during angiographic imaging.
Due to its low radiopacity, CO2 does not obscure or overlap other devices.
Sharafuddin, M. J., & Marjan, A. E. Current status of carbon dioxide angiography. Journal of vascular surgery, 66(2), 618–637. 2017
Hawkins et al. Carbon Dioxide in Angiography to Reduce the Risk of Contrast-Induced Nephropathy. Radiologic clinics of North America. 2009
Angiodroid is designed for ease of use at every stage, from setup to injection. This streamlined design optimizes procedural efficiency, saving time on device handling and facilitating smoother interventional operations.
Angiodroid is the only automatic injector proved to be simple, intuitive, and reliable.
The combined use of viscous contrast agents and thin catheters can sometimes result in incomplete vessel opacification.
CO2 is 4oo times less viscous than iodinated contrast media, which enhances injectability, facilitates filling, and increases the likelihood of successful imaging.
CO2 offers greater flexibility in angiographic procedures, enabling a variety of injection configurations.
Safe and Reliable: By managing both the volume and pressure of the injection, procedures can be standardized with patient-specific protocols that surgeons can tailor individually.
Efficient and Fast: Injections can be started either via the injector's touchscreen or the remote controller, which can be operated from the control room to minimize X-ray exposure for the surgeon and their team. The system allows for rapid sequencing, enabling a new injection just 10 seconds after the previous one.
Additionally, the CO2 injection can be synchronized with certain X-ray systems to enhance image quality and lower radiation dose.